Mid-day reversal reverses at noon, leading to modest sell-off. Adaptive and Novavax drop 9%

COVID VACCINE STOCKS started the day strong but things went south at around noon. Overall, the stocks lost 1.6% on average with 15 losing ground and 11 adding.

Novavax and Adaptive each fell just under 10% to lead the way down. Adaptive had been up by 18% on an FDA approval yesterday at the open.

EBS, Moderna, NanoViricides, BioNTech, Vir and Generex fell in the 6% range.

GeoVax gained 8% to lead on the upside while PDS and NanTKwest also had strong days up 6%.